Krishna Vaddi
CEO · Prelude Therapeutics Inc
- 2024
- Feb 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Krishna Vaddi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $12.50M in PRLD purchases and sales in the last 12 months
- David P. Bonita - $12.50M in PRLD purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $10.00M in PRLD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Krishna Vaddi?
Krishna Vaddi is a corporate insider, tracked as CEO of Prelude Therapeutics Inc (PRLD). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Krishna Vaddi last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2024.
Has Krishna Vaddi been buying or selling stock?
Recorded transactions: 2 open-market purchases ($99K) and 0 open-market sales across all tracked filings.
